Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Correction: Vol. 18, No. 2.

Meriluoto M, Hedman L, Tanner L, Simell V, Mäkinen M, Simell S, Mykkänen J, Korpelainen J, Ruuskanen O, Ilonen J, Knip M, Simell O, Hedman K, Söderlund-Venermo M.

Emerg Infect Dis. 2016 Sep;22(9):1695. doi: 10.3201/eid2209.C12209. Epub 2016 Sep 15. No abstract available.

2.

Antibodies to deamidated gliadin peptide in diagnosis of celiac disease in children.

Lammi A, Arikoski P, Simell S, Kinnunen T, Simell V, Paavanen-Huhtala S, Hinkkanen A, Veijola R, Knip M, Toppari J, Vaarala O, Simell O, Ilonen J.

J Pediatr Gastroenterol Nutr. 2015 May;60(5):626-31. doi: 10.1097/MPG.0000000000000666.

PMID:
25522308
3.

Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes.

Oresic M, Gopalacharyulu P, Mykkänen J, Lietzen N, Mäkinen M, Nygren H, Simell S, Simell V, Hyöty H, Veijola R, Ilonen J, Sysi-Aho M, Knip M, Hyötyläinen T, Simell O.

Diabetes. 2013 Sep;62(9):3268-74. doi: 10.2337/db13-0159. Epub 2013 Apr 29.

4.

Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland.

Meriluoto M, Hedman L, Tanner L, Simell V, Mäkinen M, Simell S, Mykkänen J, Korpelainen J, Ruuskanen O, Ilonen J, Knip M, Simell O, Hedman K, Söderlund-Venermo M.

Emerg Infect Dis. 2012 Feb;18(2):264-71. doi: 10.3201/eid1802.111293. Erratum in: Emerg Infect Dis. 2016 Sep;22(9):1695.

5.

Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling.

Elo LL, Mykkänen J, Nikula T, Järvenpää H, Simell S, Aittokallio T, Hyöty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O, Lahesmaa R.

J Autoimmun. 2010 Aug;35(1):70-6. doi: 10.1016/j.jaut.2010.03.001. Epub 2010 Mar 30.

PMID:
20356713
6.

Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth.

Simell S, Hoppu S, Simell T, Ståhlberg MR, Viander M, Routi T, Simell V, Veijola R, Ilonen J, Hyöty H, Knip M, Simell O.

Diabetes Care. 2010 Apr;33(4):774-9. doi: 10.2337/dc09-1217. Epub 2010 Jan 7.

7.

Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.

Siljander HT, Simell S, Hekkala A, Lähde J, Simell T, Vähäsalo P, Veijola R, Ilonen J, Simell O, Knip M.

Diabetes. 2009 Dec;58(12):2835-42. doi: 10.2337/db08-1305. Epub 2009 Sep 15.

8.

Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.

Siljander H, Härkönen T, Hermann R, Simell S, Hekkala A, Salonsaari RT, Simell T, Simell O, Ilonen J, Veijola R, Knip M.

Diabetes Metab Res Rev. 2009 Oct;25(7):615-22. doi: 10.1002/dmrr.998.

PMID:
19637309
9.

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes.

Oresic M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T, Parikka V, Katajamaa M, Hekkala A, Mattila I, Keskinen P, Yetukuri L, Reinikainen A, Lähde J, Suortti T, Hakalax J, Simell T, Hyöty H, Veijola R, Ilonen J, Lahesmaa R, Knip M, Simell O.

J Exp Med. 2008 Dec 22;205(13):2975-84. doi: 10.1084/jem.20081800. Epub 2008 Dec 15.

10.

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Näntö-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, Sipilä JI, Haavisto L, Siltala M, Tuominen J, Hakalax J, Hyöty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O.

Lancet. 2008 Nov 15;372(9651):1746-55. doi: 10.1016/S0140-6736(08)61309-4. Epub 2008 Sep 22.

PMID:
18814906
11.

Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.

Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, Tarkia M, Westerlund A, He Q, Viander M, Ilonen J, Hinkkanen AE.

Clin Exp Immunol. 2007 Nov;150(2):285-93. Epub 2007 Sep 4.

12.

Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study.

Simell S, Hoppu S, Hekkala A, Simell T, Ståhlberg MR, Viander M, Yrjänäinen H, Grönlund J, Markula P, Simell V, Knip M, Ilonen J, Hyöty H, Simell O.

Am J Gastroenterol. 2007 Sep;102(9):2026-35. Epub 2007 Jun 15.

PMID:
17573785
13.

Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease.

Westerlund A, Ankelo M, Simell S, Ilonen J, Knip M, Simell O, Hinkkanen AE.

Clin Exp Immunol. 2007 May;148(2):230-40. Epub 2007 Feb 7.

14.

Time-resolved fluorescence imaging of islet cell autoantibodies.

Vuorinen P, Rulli M, Kuusisto A, Simell S, Simell T, Vahlberg T, Ilonen J, Hyöty H, Knip M, Simell O.

Ann N Y Acad Sci. 2006 Oct;1079:226-8.

PMID:
17130559
15.

Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.

Ronkainen MS, Hoppu S, Korhonen S, Simell S, Veijola R, Ilonen J, Simell O, Knip M.

Eur J Endocrinol. 2006 Oct;155(4):633-42.

PMID:
16990664
16.

IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.

Hoppu S, Härkönen T, Ronkainen MS, Simell S, Hekkala A, Toivonen A, Ilonen J, Simell O, Knip M.

Clin Exp Immunol. 2006 Apr;144(1):59-66.

17.

Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility.

Simell S, Kupila A, Hoppu S, Hekkala A, Simell T, Ståhlberg MR, Viander M, Hurme T, Knip M, Ilonen J, Hyöty H, Simell O.

Scand J Gastroenterol. 2005 Oct;40(10):1182-91.

PMID:
16265775
18.

The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.

Hermann R, Laine AP, Veijola R, Vahlberg T, Simell S, Lähde J, Simell O, Knip M, Ilonen J.

Diabetologia. 2005 Sep;48(9):1766-75. Epub 2005 Jul 16.

PMID:
16025255
19.

Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.

Kukko M, Kimpimäki T, Korhonen S, Kupila A, Simell S, Veijola R, Simell T, Ilonen J, Simell O, Knip M.

J Clin Endocrinol Metab. 2005 May;90(5):2712-7. Epub 2005 Feb 15.

PMID:
15872335
20.

Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.

Kukko M, Virtanen SM, Toivonen A, Simell S, Korhonen S, Ilonen J, Simel O, Knip M.

Diabetes Care. 2004 Mar;27(3):676-81.

PMID:
14988284
21.

Isolation of enterovirus strains from children with preclinical Type 1 diabetes.

Salminen KK, Vuorinen T, Oikarinen S, Helminen M, Simell S, Knip M, Ilonen J, Simell O, Hyöty H.

Diabet Med. 2004 Feb;21(2):156-64.

PMID:
14984451
22.

Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes.

Hoppu S, Ronkainen MS, Kimpimäki T, Simell S, Korhonen S, Ilonen J, Simell O, Knip M.

Pediatr Res. 2004 Feb;55(2):236-42. Epub 2003 Nov 6.

PMID:
14605243
23.

Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome.

Viskari H, Paronen J, Keskinen P, Simell S, Zawilinska B, Zgorniak-Nowosielska I, Korhonen S, Ilonen J, Simell O, Haapala AM, Knip M, Hyöty H.

Clin Exp Immunol. 2003 Sep;133(3):378-83.

Supplemental Content

Loading ...
Support Center